An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis

Hematology/Oncology Clinics of North America

Volumn 12, Issue 2, 1998, Pages 407-416

  Willman, C L ^a   McClain, K L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BONE MARROW CELL; CELL SURVIVAL; CLONAL ANERGY; DENDRITIC CELL; FLOW CYTOMETRY; GENE MUTATION; HISTIOCYTOSIS; HUMAN; IMMUNOREACTIVITY; LANGERHANS CELL; METAPHASE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVIEW; STEM CELL; SURVIVAL; VIRUS INFECTION;

EID: 0031926221     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70519-0     Document Type: Article

References (44)

1. G. Abrahamson N.J. Fraser J. Boyd A highly informative X-chromosome probe, M27 can be used for the determination of tumour clonality Br J Haematol 74 1990 371
2. R.C. Allen H.Y. Zoghbi A.B. Moseley Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation Am J Hum Genet 51 1992 1229
3. F. Arenzana-Seisdedos S. Barbey J.L. Virelizier Histiocytosis X purified (T6+) cells from bone granuloma produce interleukin 1 and protaglandin E2 in culture J Clin Invest 77 1986 326
4. P. Athanasiu M. Hozoc V. Sapatino Experimental investigations in human eosinophilic granuloma. Note II. Morphologic and immunofluorescent study of cells infected in vitro with the agents isolated from three clinical cases Rev Roum D'Inframicrobiol 7 1970 125
5. B.M.N. Brinkman M.J. Giphart A. Verhoef Tumor necrosis factor a-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome Hum Immunol 41 1994 259
6. V. Broadbent E.G. Davies D. Heaf Spontaneous remission of multi-system histiocytosis X Lancet 1 1984 253
7. L. Busque D.G. Gilliland Clonal evolution in acute myeloid leukemia Blood 82 1993 337
8. P.G. Cachia D.J. Culligan E.D. Thomas Methylation of the DXS255 hypervariable locus 5′ CCGG site may be affected by factors other than X chromosome activation status Genomics 14 1992 70
9. C. Caux C. Deautter-Dambuyant D. Schmitt GM-CSF and TNFa co-operate in the generation of dendritic Langerhans cells Nature 360 1992 258
10. M.A. Collart P. Baeuerle P. Vassalli Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kB-like motifs and of constitutive and inducible forms of NF-kB Mol Cell Biol 10 1990 1498
11. L. Corbeel E. Eggermont J. Desmyter Spontaneous healing of Langerhans cell histiocytosis (histiocytosis X) Eur J Pediatr 148 1988 32
12. D.G. Gilliland K.L. Blanchard J. Levy Clonality in myeloproliferative disorders: Analysis by means of the polymerase chain reaction Proc Natl Acad Sci USA 88 1991 6848
13. A.E. Goldfield P.G. McCaffrey J.L. Strominger Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor a gene promoter J Exp Med 178 1993 1365
14. J.H. de Graaf R.Y.J. Tamminga W.A. Kamps Langerhans' cell histiocytosis: Expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation Am J Pathol 144 1994 466
15. J.S. Greenberger A.C. Crocker G. Vawter Results of treatment of 127 patients with systemic histiocytosis (Letterer-Siwe syndrome, Schuller-Christian syndrome, and multifocal eosinophilic granuloma) Medicine 60 1981 311
16. E. Hodges W.M. Howell Y. Boyd Variable X chromosome DNA methylation patterns detected with the probe M27 in a series of lymphoid and myeloid malignancies Br J Haematol 77 1991 315
17. G. Kannorakis A. Abbas The role of cytokines in the pathogenesis of Langerhans cell histiocytosis Br J Cancer 70 suppl 23 1994 S37
18. P.K. Kelley K.L. McClain Respiratory contamination of polymerase chain reactions by human herpesvirus 6 Am J Hematol 47 1994 325
19. S. Kolenik T.-G. Ding J. Longley Granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases CD1a expression by human Langerhans cells and increases proliferation in the mixed epidermal cell-lymphocyte reaction (MELR) J Invest Dermatol 95 1990 359
20. D.M. Komp Concepts in staging and clinical studies for treatment of Langerhans' cell histiocytosis Semin Oncol 18 1991 18
21. M.E. Lahey R. Heyn S. Ladisch Hypergammaglobulinemia in histiocytosis X J Pediatr 107 1985 572
22. M.A. Leahy S.M. Krejci M. Friednash Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis J Invest Dermatol 101 1993 642
23. H. Mahmoud W. Wang S.B. Murphy Cyclosporine therapy for advanced Langerhans cell histiocytosis Blood 77 1991 721
24. Marmaduke DP, Rosai J, Warnke R, et al: Molecular assessment of clonality in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): A reactive disorder of polyclonal histiocytes. Hum Pathol, submitted
25. K. McClain H. Jin V. Gresik Langerhans cell histocytosis: Lack of a viral etiology Am J Hematol 47 1994 16
26. W. McGuire A.V.S. Hill C.E.M. Allsopp Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria Nature 371 1994 508
27. J. McLelland V. Broadbent E. Yeomans Langerhans cell histiocytosis: The case for conservative treatment Arch Dis Child 65 1990 301
28. J. McLelland J.A. Newton M. Malone A flow cytometric study of Langerhans cell histiocytosis Br J Dermatol 120 1989 485
29. G.W. Mierau E.J. Willis P.O. Steele Ultrastructural studies in Langerhans cell histiocytosis: A search for evidence of virus and/or cytokine effect Med Pediatr Oncol 25 1995 133
30. E. Nastac P. Athanasiu M. Lungu Experimental investigation in human eosinphilic granuloma. Note 1. Phenolic extracts of nucleic acids from bone granulomatous tissue, pathogenic for mice Rev Roum D'Inframicrobiol 7 1970 149
31. M.E. Nesbit M. O'Leary L.P. Dehner The immune system and the histiocytosis syndromes Am J Pediatr Hematol Oncol 3 1981 141
32. W.A. Newton A.B. Hammoudi B.T. Shannon Role of the thymus in histiocytosis-X Hematol Oncol Clin North Am 1 1987 63
33. M.S. Rabkin C.T. Wittwer C.R. Kjeldsberg Flow cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis) Am J Pathol 131 1988 283
34. P. Soler M. Kambouchner D. Valeyre Pulmonary Langerhans' cell granulomatosis (histiocytosis X) Annu Rev Med 43 1992 105
35. G. Steiner E. Tschachler M. Tani Interleukin 2 receptors on cultured murine epidermal Langerhans cells J Immunol 137 1986 155
36. S. Takahiba L. Shapira S. Amar Cloning and characterization of human TNFa promoter region Gene 131 1993 307
37. J.F. Tomashefski A. Khiyami J. Kleinerman Neoplasms associated with pulmonary eosinophilic granuloma Arch Pathol Lab Med 115 1991 499
38. B. Vogelstein E.R. Fearon S.R. Hamilton Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors Science 227 1985 642
39. B. Vogelstein E.R. Fearon S.R. Hamilton Clonal analysis using recombinant DNA probes from the X-chromosome Cancer Res 47 1987 4806
40. J.S. Wainscoat M.F. Fey Assessment of clonality in human tumors: A review Cancer Res 50 1990 1355
41. C.L. Willman Detection of clonal histiocytes in Langerhans cell histiocytosis: Biology and clinical significance Br J Cancer 70 suppl 28 1994 S29
42. C.L. Willman L. Busque B.B. Griffith Langerhans cell histiocytosis (histiocytosis X): A clonal proliferative disease N Engl J Med 331 1994 154
43. A.G. Wilson N. De Vries F. Pociot An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 Alleles J Exp Med 177 1995 557
44. R.C. Yu C. Chu L. Buluwela Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis Lancet 343 1994 767